Biotricity (OTCMKTS:BTCY) Trading 0.2% Higher – Should You Buy?

Shares of Biotricity Inc. (OTCMKTS:BTCY) shot up 0.2% during trading on Monday . The company traded as high as $0.31 and last traded at $0.2925. 62,445 shares changed hands during trading, a decline of 36% from the average session volume of 98,245 shares. The stock had previously closed at $0.2920.

Biotricity Price Performance

The firm has a market cap of $8.18 million, a PE ratio of -1.72 and a beta of 1.40. The company has a 50-day simple moving average of $0.37 and a 200-day simple moving average of $0.48.

Biotricity (OTCMKTS:BTCY) last issued its quarterly earnings results on Friday, November 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.05. The business had revenue of $3.89 million for the quarter, compared to the consensus estimate of $3.90 million. As a group, equities research analysts predict that Biotricity Inc. will post -1.43 earnings per share for the current year.

About Biotricity

Biotricity (OTCMKTS:BTCY) is a medical device and digital health company specializing in remote cardiovascular monitoring and chronic disease management. The company’s flagship offering, the Bioflux system, integrates a wearable ECG patch with a cloud-based analytics platform to deliver real-time heart rhythm data and diagnostic insights. By combining wireless biosensors, mobile applications, and secure data transmission, Biotricity aims to simplify patient monitoring for healthcare providers and enhance early detection of arrhythmias and other cardiac events.

In addition to its core ambulatory ECG solution, Biotricity provides a suite of digital health products designed for broader chronic care management.